Autism Spectrum Disorder Trial, Recruiting NCT07625748 Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT07625748
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • The child must be between 4 and 10 years old
  • The child must have been diagnosed with Autism Spectrum Disorder (ASD) using specific recognised diagnostic tools (DSM-5 criteria, confirmed by specialist assessments called ADOS and/or ADI-R)
  • The child must have an IQ score of 50 or above, as measured by a standardised test
  • A parent or guardian must have signed a consent form agreeing to participation

Who may not be able to join:

  • Children who have any metal implants inside their body
  • Children who have a neurological condition such as epilepsy
  • Children whose brain MRI scan shows a structural problem that requires surgery
  • Children who have been diagnosed with a genetic or chromosomal condition (confirm with trial site)
  • Children who have been diagnosed with a mental health condition such as early-onset schizophrenia
  • Children who have a serious heart condition
  • Children who have increased pressure inside the skull (confirm with trial site)
  • Children who are already taking part in another clinical trial
  • Children who have started a new treatment or intervention programme within the 4 weeks before joining this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Registry
ClinicalTrials.gov
Start date
25 May 2026
Est. completion
30 September 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Completion of the tTIS intervention protocol; Number of participants with adverse events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov